aXichem AB (publ) (aXichem), the developer of innovative natural analogue feed additives, and Chr. Olesen, the renowned distributor, are excited to announce the latest development for aXiphen in the Brazilian market. The progress is confirmed by two upcoming commercial production tests, carried out together with poultry meat producers with significant export operations. The outline for the commercial tests were discussed at the recently held conference South American International Poultry and Swine Show (SIAVS), at Anhembi Parque, São Paulo.
Torsten Helsing, CEO at aXichem comments:
“SIAVS was an excellent opportunity for aXichem to meet with the industry and to get into more detailed discussions with the potential clients presented to us by Chr. Olesen’s team. Commercial 30-days production tests are being prepared with two poultry meat producers who are struggling with salmonella in their farms. aXiphen is now delivered from Chr. Olesen to the producers, who are both based in the south of Brazil. We are excited to prove that aXiphen can play an important role as an innovative feed additive, supporting a sustainable and safe poultry meat production. I’m also pleased about the positive impact on aXichem’s cash flow with just over SEK two million as the product moves from distributor to end-customer.”
Gustavo Penz, Managing Partner, Feed Division Brazil at Chr. Olesen comments:
“We are very pleased to be moving forward with these well-established and experienced meat producers, who in average slaughter 100,000-500,000 birds per day. Salmonella is a huge and costly problem for the poultry meat industry in Brazil and producers are constantly searching for preventing measures. aXiphen is a new and innovative feed additive presenting well documented salmonella inhibition capabilities as well as gut health benefits and competitive return on investment. All in all, a very exciting offer to the industry.”
About Chr. Olesen
As a global distributor in the animal health and nutrition industry, Chr. Olesen is committed to delivering high-quality, safe, and sustainable solutions, contributing to the advancement of the animal production sector.
The information was submitted, through the care of the contact person below, for publication on 14 August 2024, at 8:30 CET.
Company contact: Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355 Email: torsten.helsing@axichem.com
About aXichem aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio- enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.
